Literature DB >> 3144943

Cerebellar ataxia in systemic lupus erythematosus: three case reports.

R R Singh1, K Prasad, A Kumar, A Misra, K Padmakumar, A N Malaviya.   

Abstract

Three patients presented with cerebellar ataxia among 350 cases of systemic lupus erythematosus (SLE) seen over the last 14 years. Cerebellar signs were unilateral in one and bilateral in the other two patients. Other neurological findings were present in all three patients. One initially presented with only cerebellar ataxia; other features of SLE appeared a few years later. Lupus anticoagulant test was positive in one patient. Corticosteroids given in the early stages appeared to benefit these patients by ameliorating cerebellar dysfunction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144943      PMCID: PMC1003639          DOI: 10.1136/ard.47.11.954

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis.

Authors:  J S Sergent; M D Lockshin; M S Klempner; B A Lipsky
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

2.  Anti-cardiolipin antibodies and the lupus anticoagulant.

Authors:  E N Harris; G R Hughes; A E Gharavi
Journal:  Clin Exp Rheumatol       Date:  1986 Apr-Jun       Impact factor: 4.473

3.  Association of lupuslike anticoagulant and nonvasculitic cerebral infarction.

Authors:  N F Tabachnik-Schor; S A Lipton
Journal:  Arch Neurol       Date:  1986-08

4.  A DNA antigen that reacts with antisera to cardiolipin.

Authors:  M Guarnieri; D Eisner
Journal:  Biochem Biophys Res Commun       Date:  1974-05-20       Impact factor: 3.575

Review 5.  The neuropsychiatric manifestations of systemic lupus erythematosus: an overview.

Authors:  D C Adelman; E Saltiel; J R Klinenberg
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532

6.  Cerebellar ataxia in systemic lupus erythematosus.

Authors:  A J Tuchman; M Daras; S David
Journal:  N Y State J Med       Date:  1983-06

7.  Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies.

Authors:  R A Asherson; R H Derksen; E N Harris; B N Bouma; A E Gharavi; L Kater; G R Hughes
Journal:  Semin Arthritis Rheum       Date:  1987-05       Impact factor: 5.532

8.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

Authors:  E M Lafer; J Rauch; C Andrzejewski; D Mudd; B Furie; B Furie; R S Schwartz; B D Stollar
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

Review 9.  Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.

Authors:  E J Feinglass; F C Arnett; C A Dorsch; T M Zizic; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

10.  A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Authors:  T Exner; K A Rickard; H Kronenberg
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

View more
  13 in total

Review 1.  Cerebellum vasculopathy and normal tension glaucoma in systemic lupus erythematosus: report of a case and review of the literature.

Authors:  Alice Y K Chan; Edmund K Li; Grace L H Wong; David T L Liu
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

Review 2.  Cerebellar ataxia and obstructive hydrocephalus, rare neurologic presentations in patients with systemic lupus erythematosus.

Authors:  Hamdy Mohamed Abdelaziz Ahmed; Rasmia El-Gohary; Fatema Fayed; Hala El-Gendy
Journal:  Rheumatol Int       Date:  2017-07-13       Impact factor: 2.631

Review 3.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

Review 4.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

5.  Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases.

Authors:  R W Smith; D W Ellison; E A Jenkins; P J Gallagher; M I Cawley
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

6.  Neurobehavioural changes and morphological study of cerebellar purkinje cells in kaolin induced hydrocephalus.

Authors:  Funmilayo Eniola Olopade; Omowumi Femi-Akinlosotu; Adejoke Joan Adekanmbi; Seun Ajani; Matthew Temitayo Shokunbi
Journal:  Anat Sci Int       Date:  2020-08-13       Impact factor: 1.741

Review 7.  Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction.

Authors:  P M Moore; R P Lisak
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Cerebellar atrophy in systemic sclerosis.

Authors:  Luís Pinheiro; João Freitas; Margarida Lucas; Rui M M Victorino
Journal:  J R Soc Med       Date:  2004-11       Impact factor: 18.000

Review 9.  Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Keya Adhikari; Daniel Aeschlimann; Partha Chattopadhyay; Marios Hadjivassiliou; Christiane S Hampe; Jérôme Honnorat; Bastien Joubert; Shinji Kakei; Jongho Lee; Mario Manto; Akiko Matsunaga; Hidehiro Mizusawa; Kazunori Nanri; Priya Shanmugarajah; Makoto Yoneda; Nobuhiro Yuki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

10.  Commentary.

Authors:  Khaled Saad; Reda Badry
Journal:  J Neurosci Rural Pract       Date:  2014-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.